Overweight, obesity and features of metabolic syndrome in children with diabetes treated with insulin pump therapy
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : W³odzimierz £uczyٌski & Agnieszka Szypowska & Barbara G³owiٌska-Olszewska & Artur Bossowski
- چاپ و سال / کشور: 2011
Description
There has been no specific evaluation of atherogenic risk factors in children with type 1 diabetes mellitus (T1DM) treated with continuous subcutaneous insulin infusion (CSII). We, therefore, studied the prevalence of overweight/obesity and metabolic syndrome among these patients. Five hundred children with T1DM treated with CSII and multiple daily insulin (MDI) regimen were included in the study. Anthropometric data/physical examination, data concerning diabetes, and a lipid profile were assessed in this group, and compared with respect to treatment method (CSII vs. MDI). Almost one-third (30.2%) of the children were overweight/obese. The body mass index (BMI) values at the time of the present evaluation were significantly higher in comparison with the BMI values 3–6 months after the diagnosis. Dyslipidemia was recognized in 51.6%, hypertension in 4.8%, and the metabolic syndrome in 3.2%. of the subjects. The overweight/obese children differed from their normalweight counterparts with respect to metabolic control, the incidence of hypertension, dyslipidemia, and metabolic syndrome. The girls showed higher prevalence of overweight/ obesity and higher BMI values compared to the boys. The children treated with CSII had the same prevalence of overweight/obesity, but a lower incidence of dyslipidemia, and a better metabolic control compared to the children treated with MDI regimen. Our study shows a high prevalence of overweight/obesity and dyslipidemia in children with T1DM including those treated with an insulin pump.
Eur J Pediatr (2011) 170:891–898 DOI 10.1007/s00431-010-1372-7, Received: 12 September 2010 / Accepted: 24 November 2010 / Published online: 8 December 2010
